$120-$340/hr cutaneous diagnostic work, on your schedule
You grade a model's lesion reads, differentials, and management plans, catching the amelanotic melanoma it calls benign. You explain the morphology and distribution a textbook caption leaves out, remote and paid by the hour.
Trusted by top research companies
Hi, we're Zac and Jack, the founders of Terac. We want to talk to you directly, because you are the most important part of what we're building.
Terac is a community of experts. People who have spent years getting good at something specific and hard. The world is about to need more of you, not less. As AI takes on more of the world's work, the bottleneck shifts to the people who actually know what they're talking about.
Expert labor is the rarest resource in the world right now, and it is shockingly hard to find. The companies that need a dermatologist's eye on a missed amelanotic melanoma spend weeks chasing people, paying placement fees, and settling for whoever is available. Meanwhile thousands of qualified people are sitting with knowledge that no one ever asks for.
That gap is what we're here to close. Every project that lands on Terac is routed to the people who actually know the answer, on their schedule, paid fairly, and only when the work is verified. No middleman taking a cut of your time. No vague gigs. No chasing checks.
We care about every single person in this community. If you join Terac, you're not a row in a database to us. We read the feedback. We answer the emails. We will fight for you when a customer is being unreasonable, and we will be honest with you when something on our side is broken. The quality of this panel is our entire company, and we owe you a serious bar.
If you've made it this far, here is what we're asking: claim your profile. Put your expertise on the record. Let the world's most ambitious teams come find you for the work only you can do.
Dermatology questions
Still curious? Write to us at support@terac.com.
Skin cancer hides in subtle patterns a general model misreads, and a missed melanoma is fatal. Your dermoscopic eye and biopsy judgment catch the dangerous lesion called benign. That pattern recognition is exactly what the work pays for.
Yes. We verify board certification and an active or recent US license. Dermoscopy, Mohs surgery, or dermatopathology experience routes you to higher-paying oncologic and imaging review work.
No. You evaluate lesion reads and management plans, never a real patient. There is no doctor-patient relationship and no clinical liability. You judge whether the model's reasoning is accurate and safe.
Lesion descriptions and dermoscopic reads, differential diagnoses, biopsy and management recommendations, and melanoma and skin cancer staging notes. You grade each for morphologic accuracy, appropriate biopsy decisions, and standard of care.
Flag it as the highest-severity error. Identify any read that calls a malignant or suspicious lesion benign, explain the dermoscopic and morphologic features the model ignored, and describe the correct biopsy decision so the system learns not to miss cancer.
Why your expertise matters
Today's dermatology AI flattens the morphology that hides a killer in plain sight. It calls an amelanotic melanoma benign, misses a drug reaction turning life-threatening, and miscounts Breslow depth. Telling an atypical nevus from an early melanoma takes a dermatologist, not a morphology list. Your corrections teach the model not to miss the cancer that matters.
How pay works
Work pays $120 to $340 an hour, with dermoscopy, Mohs, and dermatopathology depth plus detailed lesion interpretation at the top. Bill for time spent evaluating lesion reads, differentials, and management plans. Most dermatologists work a few flexible hours a week.
What the work looks like
A sample of the cutaneous diagnostic work you would pick up. Every project is scoped, remote, and paid on verified completion.
- Catch the AI lesion read that calls an amelanotic melanoma a benign growth and recommends reassurance over biopsy.
- Spot the severe drug reaction, such as Stevens-Johnson syndrome, an AI differential misses in a widespread eruption with mucosal involvement.
- Flag the atypical network and blue-white veil suggesting melanoma that a machine-written dermoscopy interpretation overlooks.
- Decide which of two AI management plans for a suspicious pigmented lesion correctly recommends excisional biopsy over a shave.
- Critique an AI staging note that records the wrong Breslow depth and understages a melanoma.
- Reject an AI plan for a recurrent facial basal cell carcinoma that ignores Mohs candidacy in a cosmetically sensitive site.
Specialties we match
Dermatology projects span a wide range of focus areas. Tell us where you go deep and we route the work that fits.
- Dermoscopic pattern interpretation
- Biopsy decision-making and technique selection
- Melanoma recognition and Breslow staging
- Nonmelanoma skin cancer assessment
- Drug eruption and severe cutaneous reaction recognition
- Inflammatory and autoimmune skin disease diagnosis
- Morphology, distribution, and configuration analysis
- Pigmented lesion risk stratification
- Mohs candidacy and margin considerations
- Dermatopathology correlation
- Pediatric and skin-of-color presentation nuance
- Differentiating benign from malignant lesions
